openPR Logo
Press release

Mycoprotein market Market to witness 5.7% of High CAGR by Forecast 2029, Trends, Demands, Key Players and Regional Analysis

11-30-2022 10:45 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Exactitude Consultancy

Mycoprotein market Market to witness 5.7% of High CAGR

Growth of Mycoprotein market is scheduled to accelerate at a high CAGR of 5.7 % to reach USD 948.86 million by 2029.

Mycoprotein market Overview

Qualitative analysis about Mycoprotein market status (2022 To 2029), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2019 to 2029), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analysed scientifically, the feature of product circulation and sales Distribution will be presented as well.

Mycoprotein is a high-protein plant-based ingredient that is primarily used as a meat substitute in a variety of foods and beverages due to its cholesterol-lowering, satiety, and nutritious properties. The global market for mycoprotein products is expected to grow rapidly due to the increasing demand for high quality protein diets and increasing adoption of veganism.

Rise in the incidence of illness is expected to drive the mycoprotein products market with increased health and fitness awareness among consumers. In addition, the rapid development of the catering industry and the attractive marketing and promotional strategies of vegetarian companies have contributed to the growth of the global economy.

Enquiry for Free Sample Pages before Purchase:

https://exactitudeconsultancy.com/reports/3290/mycoprotein-market/#request-a-sample?Mode=RN169

The comprehensive Demand analysis of the Mycoprotein market will assist in managing better product differentiation, along with detailed understanding of the core capability of each activity involved. The Mycoprotein market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.

Following are the major Companies of Mycoprotein market - 3F Bio Ltd, General Mills, Marlow Foods Ltd, MycoTechnology, Inc., Temasek Holdings, Tyson Ventures and others.

Recent Developments

Quorn Foods is trying to stay as an appealing provider with investments in marketing and category management of their meat substitute and mycoprotein brand "Quorn". The company invests 15% of its revenue in the marketing of meat substitute products and spends 12 million euros annually on R&D

Argentinian tech firm Enye Technologies has optimized the production process for mycoprotein products, allowing for cheaper production both industrially and at home. The company is focusing on the development of mycoprotein products for business to business (B2B) and business to consumers (B2C) by establishing joint licensing ventures with food companies and multinationals.

Mycoprotein market Segmentation:
Based on the industrial chain, this report mainly indicates the definition, types, applications and major players of Mycoprotein market in details.

Mycoprotein Market by Type, 2020-2029, (USD Million) (Kilotons)

Feed Grade Mycoprotein

Food Grade Mycoprotein

Mycoprotein Market by Application, 2020-2029, (USD Million) (Kilotons)

Meat Alternatives

Pet Food

Feed

Browse Complete Premium 149 Pages Report and TOC:

https://exactitudeconsultancy.com/reports/3290/mycoprotein-market/

Mycoprotein market Regional Analysis:
Mycoprotein market research targets on volume and value at regional Opportunity and company Trends From a global perspective, this report Study represents overall market analysed on historical data and future growth Aspects. Geographically, Mycoprotein market report focuses on following key regions: Americas, Europe, Asia-Pacific, Middle East & Africa and ROW.

Growth Market Overview:
Digital transformation of Mycoprotein industry verticals requires broadband services, thereby promoting growth. For instance, increasing online commerce for retail goods and services, digitalization of hospital records, e-government initiatives, and rapidly rising platforms for media and entertainment content are notably augmenting the market growth. Wireless technology holds immense potential in accelerating the global digital revolution across verticals through productivity enhancements and cost-effectiveness.

Grab Latest Press Release:

https://exactitudeconsultancy.com/post/mycoprotein-market-growth/

Top Change Bringing Technologies

Industrial Internet of Things
Artificial Intelligence
Just in Time
Smart Packaging
Additive Manufacturing
Predictive Maintenance

About Us

Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

Connect Us:

PHONE NUMBER +1 (704) 266-3234

EMAIL ADDRESS: sales@exactitudeconsultancy.com

LinkedIn: https://www.linkedin.com/company/exactitudeconsultancy/

Twitter: https://twitter.com/ExactitudeCons

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mycoprotein market Market to witness 5.7% of High CAGR by Forecast 2029, Trends, Demands, Key Players and Regional Analysis here

News-ID: 2828256 • Views:

More Releases from Exactitude Consultancy

Relapsed/Refractory Acute Myeloid Leukemia Market is expected to reach USD 6.1 billion by 2034
Relapsed/Refractory Acute Myeloid Leukemia Market is expected to reach USD 6.1 b …
Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy characterized by the rapid proliferation of abnormal myeloid cells in the bone marrow and blood. Despite advances in frontline therapies, relapse is common, and many patients develop refractory disease, leaving limited treatment options and poor survival outcomes. Relapsed/refractory AML (R/R AML) remains a major unmet clinical need. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71571 In recent years, however, the
Retinoblastoma Market to Reach USD 1.2 Billion by 2034
Retinoblastoma Market to Reach USD 1.2 Billion by 2034
Retinoblastoma is a rare pediatric eye cancer that originates in the retina and primarily affects children under five years of age. It accounts for around 3% of all childhood cancers but is the most common intraocular malignancy in children. With improved awareness, early screening, and advances in treatment, survival rates in developed nations exceed 90%. However, challenges remain in low- and middle-income countries where delayed diagnosis and limited access to
Severe Toxicities in Lymphoma Market Projected to Reach USD 3.7 Billion by 2034
Severe Toxicities in Lymphoma Market Projected to Reach USD 3.7 Billion by 2034
Lymphoma, a group of blood cancers affecting the lymphatic system, is broadly classified into Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL). While survival outcomes have improved significantly with chemotherapy, radiotherapy, targeted agents, and immunotherapies, many patients experience severe toxicities as side effects of treatment. These toxicities - ranging from cytokine release syndrome (CRS) and neurotoxicity in CAR-T therapy to myelosuppression, infections, and organ toxicities from chemotherapy and immunomodulators - can
Soft Tissue Neoplasms Market to Reach USD 6.0 Billion by 2034
Soft Tissue Neoplasms Market to Reach USD 6.0 Billion by 2034
Soft tissue neoplasms are abnormal growths arising from connective tissues, including muscles, fat, nerves, tendons, and blood vessels. While some are benign, malignant forms such as soft tissue sarcomas (STS) pose serious clinical challenges due to their aggressive nature, rarity, and diverse histological subtypes. Representing about 1% of all adult cancers, these neoplasms require a wide spectrum of treatments ranging from surgery and radiotherapy to chemotherapy and novel targeted therapies. Download

All 5 Releases


More Releases for Mycoprotein

Mycoprotein Market Insights 2024 Meeting the Rising Demand for Alternative Prote …
latest recently released a research report titled global Mycoprotein Market insight, forecast to 2024 -2030, which assesses various factors influencing its trajectory. The report presents a high-quality, accurate, and comprehensive research study to provide players with valuable insights for making strategic business decisions. The research analysts have conducted an in-depth segmental analysis of the global Mycoprotein market based on type, application, and geography. The vendor landscape is also illuminated to
Mycoprotein Market Size, Share, Trends, Growth, Forecast & Insights 2024-2031
What is the Global Mycoprotein Market? The Global Mycoprotein Market encompasses the production, distribution, and consumption of mycoprotein, a protein-rich, plant-based nutrient. Mycoprotein serves as a popular meat substitute, particularly among vegan and vegetarian consumers, due to its high protein and fiber content, low saturated fat, and absence of cholesterol. Global Mycoprotein Market Overview: The Global Mycoprotein Market is projected to grow at a CAGR of 5.5% from 2024 to 2031, driven by
Mycoprotein Meat Substitute Market May See a Big Move | Eternal, Symrise, Mycore …
Advance Market Analytics published a new research publication on "Mycoprotein Meat Substitute Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Mycoprotein Meat Substitute market was mainly driven by the increasing R&D spending across the world. Some of the key players
Global Mycoprotein Market Recovery And COVID-19 Impact Between 2023 And 2028
Market size and share analysis of the worldwide Mycoprotein Industry The Mycoprotein research report examines manufacturing processes and cost structures as well as development strategies and tactics. In this report, the analyst provide a detailed survey of the global Mycoprotein market and provide insights into the development of the market based on manufacturers, market segments, and various other factors that will help readers and stakeholders to gain a better understanding of
Mycoprotein Products Market – The Vegetarian 'Meat' Claiming Extraordinary Sta …
Global Mycoprotein Products Market – Scope of the Report The following report provides forecast and analysis of the global mycoprotein products market along with the historical data of 2013, estimated data 2019 and forecast data up to 2027 in terms of revenue (US$ Mn) and volume (Tons), according to a Fact.MR study. Click HERE to Get Complete Synopsis of the Report- https://www.factmr.com/report/4185/mycoprotein-products-market The research propounds critical trends that are currently influencing growth within
Mycoprotein Market: Competitive Dynamics & Global Outlook 2020-2025
Global Info Research offers a latest published report on Mycoprotein Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Mycoprotein Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/reports/513490/mycoprotein Market Overview The Mycoprotein